Structural properties of matrix metalloproteinases

被引:309
作者
Bode, W [1 ]
Fernandez-Catalan, C
Tschesche, H
Grams, F
Nagase, H
Maskos, K
机构
[1] Max Planck Inst Biochem, D-82152 Martinsried, Germany
[2] Univ Bielefeld, Abt Biochem 1, D-33615 Bielefeld, Germany
[3] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA
关键词
matrix metalloproteinases (MMPs); tissue inhibitors of metalloproteinases (TIMPs); crystal structures; proteinases; drug design;
D O I
10.1007/s000180050320
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix metalloproteinases (MMPs) are involved in extracellular matrix degradation. Their proteolytic activity must. be precisely regulated by their endogenous protein inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). Disruption of this balance results in serious diseases such as arthritis, tumour growth and metastasis. Knowledge of the tertiary structures of the proteins involved is crucial for understanding their functional properties and interference with associated dysfunctions. Within the last few years, several three-dimensional MMP and MMP-TIMP structures became available, showing the domain organization, polypeptide fold and main specificity determinants. Complexes of the catalytic MMP domains with various synthetic inhibitors enabled the structure-based design and improvement of high-affinity ligands, which might be elaborated into drugs. A multitude of reviews surveying work done on all aspects of MMPs have appeared in recent years, but none of them has focused on the three-dimensional structures. This review was written to close the gap.
引用
收藏
页码:639 / 652
页数:14
相关论文
共 89 条
  • [1] ALSCRIPT - A TOOL TO FORMAT MULTIPLE SEQUENCE ALIGNMENTS
    BARTON, GJ
    [J]. PROTEIN ENGINEERING, 1993, 6 (01): : 37 - 40
  • [2] STROMELYSIN-1 - 3-DIMENSIONAL STRUCTURE OF THE INHIBITED CATALYTIC DOMAIN AND OF THE C-TRUNCATED PROENZYME
    BECKER, JW
    MARCY, AI
    ROKOSZ, LL
    AXEL, MG
    BURBAUM, JJ
    FITZGERALD, PMD
    CAMERON, PM
    ESSER, CK
    HAGMANN, WK
    HERMES, JD
    SPRINGER, JP
    [J]. PROTEIN SCIENCE, 1995, 4 (10) : 1966 - 1976
  • [3] Matrix metalloproteinase inhibitors 1998
    Beckett, RP
    Whittaker, M
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (03) : 259 - 282
  • [4] MATRIX METALLOPROTEINASES - A REVIEW
    BIRKEDALHANSEN, H
    MOORE, WGI
    BODDEN, MK
    WINDSOR, LJ
    BIRKEDALHANSEN, B
    DECARLO, A
    ENGLER, JA
    [J]. CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1993, 4 (02) : 197 - 250
  • [5] A HELPING HAND FOR COLLAGENASES - THE HEMOPEXIN-LIKE DOMAIN
    BODE, W
    [J]. STRUCTURE, 1995, 3 (06) : 527 - 530
  • [6] THE X-RAY CRYSTAL-STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN NEUTROPHIL COLLAGENASE INHIBITED BY A SUBSTRATE-ANALOG REVEALS THE ESSENTIALS FOR CATALYSIS AND SPECIFICITY
    BODE, W
    REINEMER, P
    HUBER, R
    KLEINE, T
    SCHNIERER, S
    TSCHESCHE, H
    [J]. EMBO JOURNAL, 1994, 13 (06) : 1263 - 1269
  • [7] STRUCTURE OF ASTACIN AND IMPLICATIONS FOR ACTIVATION OF ASTACINS AND ZINC-LIGATION OF COLLAGENASES
    BODE, W
    GOMISRUTH, FX
    HUBER, R
    ZWILLING, R
    STOCKER, W
    [J]. NATURE, 1992, 358 (6382) : 164 - 167
  • [8] ASTACINS, SERRALYSINS, SNAKE-VENOM AND MATRIX METALLOPROTEINASES EXHIBIT IDENTICAL ZINC-BINDING ENVIRONMENTS (HEXXHXXGXXH AND MET-TURN) AND TOPOLOGIES AND SHOULD BE GROUPED INTO A COMMON FAMILY, THE METZINCINS
    BODE, W
    GOMISRUTH, FX
    STOCKLER, W
    [J]. FEBS LETTERS, 1993, 331 (1-2) : 134 - 140
  • [9] STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR
    BORKAKOTI, N
    WINKLER, FK
    WILLIAMS, DH
    DARCY, A
    BROADHURST, MJ
    BROWN, PA
    JOHNSON, WH
    MURRAY, EJ
    [J]. NATURE STRUCTURAL BIOLOGY, 1994, 1 (02): : 106 - 110
  • [10] Matrix metalloproteinase inhibitors in arthritis
    Bottomley, KM
    Johnson, WH
    Walter, DS
    [J]. JOURNAL OF ENZYME INHIBITION, 1998, 13 (02): : 79 - 101